Hospital Innovations is celebrating a decade of business, in a year that has seen it hit a series of significant milestones
Having built an enviable reputation for delivering an array of products targeted towards the orthopaedic and surgical sectors, which enable practitioners to afford patients with a variety of procedural options, Hospital Innovations has seen its range of meshed and unmeshed human cryopreserved skin products used on more than 50,000 patients.
An industry-leading range of innovative products that facilitate life-changing operations for people that have suffered traumatic third-degree burns, the cryopreserved skin is key to preventing the possibility of bacterial contamination and the loss of body fluids.
As well as facilitating its 50,000th graft, the company has also surpassed the £50million sales benchmark, to cement its stature as a prominent member of the South Wales business community.
On the trio of landmarks that the company has achieved, Managing Director Phil Davies said: “Reaching a decade of business operations is a huge achievement and I’m massively proud of where we’ve come over that time.
“The team continues to add new products to the company’s portfolio and build relationships with new clients in new sectors and I feel the future of the organisation is extremely bright.
“To have hit three significant landmarks so quickly is testament to the hard work of the team. From here we hope to build a long-lasting heritage for the business, based on delivering increased innovation and choice for hospitals and patients across the UK.”
Founded in 2008, Hospital Innovations is a Human Tissue Authority (HTA) licensed supplier of specialist products used in orthopaedic and corrective surgeries and works in partnership with four of the world’s leading tissue banks.
The Talbot Green-based company specialises in creating innovative, safe and effective solutions to hospitals and clinics and has grown into a globally trading company.